<?xml version="1.0" ?>
<document id="474dc8b54f9110f60b129220549c532355fe10b2">
  <chunk id="474dc8b54f9110f60b129220549c532355fe10b2.c0" text="The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis">
    <entity charOffset="33-39" id="474dc8b54f9110f60b129220549c532355fe10b2.c0.e0" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="60-66" id="474dc8b54f9110f60b129220549c532355fe10b2.c0.e1" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="141-156" id="474dc8b54f9110f60b129220549c532355fe10b2.c0.e2" ontology_id="DOID_1936" text="atherosclerosis" type="disease"/>
    <pair e1="474dc8b54f9110f60b129220549c532355fe10b2.c0.e0" e2="474dc8b54f9110f60b129220549c532355fe10b2.c0.e2" id="474dc8b54f9110f60b129220549c532355fe10b2.c0.p0" relation="true"/>
    <pair e1="474dc8b54f9110f60b129220549c532355fe10b2.c0.e1" e2="474dc8b54f9110f60b129220549c532355fe10b2.c0.e2" id="474dc8b54f9110f60b129220549c532355fe10b2.c0.p1" relation="true"/>
  </chunk>
  <chunk id="474dc8b54f9110f60b129220549c532355fe10b2.c1" text="Waumans Y, Baerts L, Kehoe K, Lambeir A-M and De Meester I (2015) The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis.">
    <entity charOffset="99-105" id="474dc8b54f9110f60b129220549c532355fe10b2.c1.e0" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="126-132" id="474dc8b54f9110f60b129220549c532355fe10b2.c1.e1" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
  </chunk>
  <chunk id="474dc8b54f9110f60b129220549c532355fe10b2.c2" text="Research from over the past 20 years has implicated dipeptidyl peptidase (DPP) IV and its family members in many processes and different pathologies of the immune system. Most research has been focused on either DPPIV or just a few of its family members. It is, however, essential to consider the entire DPP family when discussing any one of its members. There is a substantial overlap between family members in their substrate specificity, inhibitors, and functions. In this review, we provide a comprehensive discussion on the role of prolyl-specific peptidases DPPIV, FAP, DPP8, DPP9, dipeptidyl peptidase II, prolyl carboxypeptidase, and prolyl oligopeptidase in the immune system and its diseases. We highlight possible therapeutic targets for the prevention and treatment of atherosclerosis, a condition that lies at the frontier between inflammation and cardiovascular disease.">
    <entity charOffset="74-77" id="474dc8b54f9110f60b129220549c532355fe10b2.c2.e0" ontology_id="CHEBI_34680" text="DPP" type="chemical"/>
    <entity charOffset="304-307" id="474dc8b54f9110f60b129220549c532355fe10b2.c2.e1" ontology_id="CHEBI_34680" text="DPP" type="chemical"/>
    <entity charOffset="529-533" id="474dc8b54f9110f60b129220549c532355fe10b2.c2.e2" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="613-619" id="474dc8b54f9110f60b129220549c532355fe10b2.c2.e3" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="642-648" id="474dc8b54f9110f60b129220549c532355fe10b2.c2.e4" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
  </chunk>
  <chunk id="474dc8b54f9110f60b129220549c532355fe10b2.c3" text="Keywords: dipeptidyl peptidase, prolyl oligopeptidase, fibroblast activation protein α α α, prolyl carboxypeptidase, inflammation, immunophysiology, atherosclerosis Frontiers in Immunology | www.frontiersin.org">
    <entity charOffset="32-38" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.e0" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="77-84" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.e1" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="92-98" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.e2" ontology_id="CHEBI_26274" text="prolyl" type="chemical"/>
    <entity charOffset="149-164" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.e3" ontology_id="DOID_1936" text="atherosclerosis" type="disease"/>
    <pair e1="474dc8b54f9110f60b129220549c532355fe10b2.c3.e0" e2="474dc8b54f9110f60b129220549c532355fe10b2.c3.e3" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.p0" relation="true"/>
    <pair e1="474dc8b54f9110f60b129220549c532355fe10b2.c3.e1" e2="474dc8b54f9110f60b129220549c532355fe10b2.c3.e3" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.p1" relation="true"/>
    <pair e1="474dc8b54f9110f60b129220549c532355fe10b2.c3.e2" e2="474dc8b54f9110f60b129220549c532355fe10b2.c3.e3" id="474dc8b54f9110f60b129220549c532355fe10b2.c3.p2" relation="true"/>
  </chunk>
  <chunk id="474dc8b54f9110f60b129220549c532355fe10b2.c4" text="August 2015 | Volume 6 | Article 387 FIGURE 1 | The DPP family. Summary of the names, the localization, and most important field of action of all members of the DPP family.">
    <entity charOffset="52-55" id="474dc8b54f9110f60b129220549c532355fe10b2.c4.e0" ontology_id="CHEBI_34680" text="DPP" type="chemical"/>
    <entity charOffset="132-138" id="474dc8b54f9110f60b129220549c532355fe10b2.c4.e1" ontology_id="CHEBI_5133" text="action" type="chemical"/>
    <entity charOffset="161-164" id="474dc8b54f9110f60b129220549c532355fe10b2.c4.e2" ontology_id="CHEBI_34680" text="DPP" type="chemical"/>
  </chunk>
</document>
